Victor J Hruby

USPTO Granted Patents = 39 (Patent Applications = 10)

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 2.7

ph-index = 12

Forward Citations = 582(Granted Patents)

Company Filing History:

25 out of 973

The University of Arizona

patents

5 out of 224

University Patents, Inc.

patents

4 out of 291

H. Lee Moffitt Cancer Center and Research Institute, Inc.

patents

4. 4 out of 37

Intezyne Technologies, Incorporated

patents

5. 4 out of 5,469

The University of Texas System

patents

6. 3 out of 26

Competitive Technologies, Inc.

patents

7. 2 out of 2

Gibson-stephens Neuropharmaceuticals, Inc.

patents

8. 2 out of 11

Arizona Technology Development Corporation

patents

9. 2 out of 1,246

The Texas A&M University System

patents

10. 1 out of 1

Gibson-stephens Institute

patent

11. 1 out of 119

The Translational Genomics Research Institute

patents

12. 1 out of 266

University of Hawai'i

patents

13. 1 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 1984-2025

Loading Chart...

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12440570 - Conjugation of MCR1 ligand with cytotoxic drugs for treating skin cancer (2025-10-14),

2. 12173087 - Melanocortin 1 receptor ligands and methods of use (2024-12-24),

3. 11970521 - Neuroprotective beta amyloid core peptides and peptidomimetic derivatives (2024-04-30),

4. 11542302 - Modulators of melanocortin receptors for the treatment of depression and anxiety (2023-01-03),

5. 11440885 - Substituted 1-arylalkyl-4-acylaminopiperidine compounds and methods of producing and using the same (2022-09-13),

6. 11230568 - Melanocortin 1 receptor ligands and methods of use (2022-01-25),

7. 11141452 - Bifunctional compounds for relief of pain comprising an opioid receptor agonist moiety and a NK1 receptor antagonist moiety and methods for treating pain (2021-10-12),

8. 11124542 - Modulators of melanocortin receptors (2021-09-21),

9. 10766925 - Opioid receptor modulators (2020-09-08),

10. 10653743 - Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N (2020-05-19),

11. 10617681 - 1-arylalkyl-4-acylaminopiperidine compounds (2020-04-14),

12. 10550157 - Compositions and methods for treating central nervous system (CNS) disorders and mood disorders (2020-02-04),

13. 10428115 - Dynorphin A analogs with bradykinin receptors specificity for modulation of neuropathic pain (2019-10-01),

14. 10329326 - Melanocortin 1 receptor ligands and methods of use (2019-06-25),

15. 10188704 - Enhanced melanoma cancer prevention by novel melanotropins (2019-01-29),

Title: The Innovative Journey of Victor J Hruby

Introduction: Victor J Hruby, a distinguished inventor hailing from Tucson, AZ, has made significant contributions to the field of science and technology through his groundbreaking inventions.

Latest Patents: Victor J Hruby holds several patents in the areas of biotechnology and pharmaceuticals, with his most recent patent focusing on a novel drug delivery system for targeted cancer therapy.

Career Highlights: Throughout his illustrious career, Victor J Hruby has been recognized for his pioneering work in peptide chemistry and drug design. His research has led to the development of innovative treatments for various medical conditions.

Collaborations: Victor J Hruby has collaborated with leading research institutions and pharmaceutical companies to further advance his inventions. His partnerships have resulted in the successful translation of his research into real-world applications.

Conclusion: Victor J Hruby's passion for innovation and dedication to scientific advancement have solidified his reputation as a trailblazer in the field of biotechnology. His contributions continue to have a profound impact on the lives of many, making him a true visionary in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.